Skip to main content

AndroGel Sales Data

Rank 35 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows AndroGel U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 35 (1) 5.47% -1.76%
Q3 2013 34 (2) -3.42% -2.99%
Q2 2013 36 (1) -0.84% -2.79%
Q1 2013 37 (1) 0.49% -40.11%
Q4 2012 36 (1) -0.34% -15.96%
Q3 2012 37 (7) 6.38% -4.66%
Q2 2012 44 (3) 4.81% -13.78%
Q1 2012 47 (6) 11.20% 4.43%
Q4 2011 53 (3) 5.44% -4.80%
Q3 2011 50 (1) -5.89% -8.93%
Q2 2011 49 (7) 6.52% 93.39%
Q1 2011 56 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.